MedTrace Logo

Nasal Expiratory Resistance in Patients With Sleep Apnea and Expiratory Flow Limitation

NCT02612038 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2022-03-09

No results posted yet for this study

Summary

Obstructive sleep apnea (OSA) is inherently site-specific. In a physiological controlled intervention study, the investigators seek to determine whether applying expiratory resistance can acutely improve ventilation and sleep in patients with expiratory flow limitation (EFL).

Conditions

Interventions

DEVICE

Expiratory resistance

Generic expiratory resistance will be added to the patient's respiratory circuit

DEVICE

Sham expiratory resistance

Sham expiratory resistance will be added to the patient's respiratory circuit

Sponsors & Collaborators

  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Andrew Wellman, PhD MD · Brigham and Women's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-01
Primary Completion
2017-05-01
Completion
2017-05-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02612038 on ClinicalTrials.gov